Intelligent Bio Solutions Inc. (INBS)
- Previous Close
2.4100 - Open
2.3000 - Bid 2.3400 x 200
- Ask 2.4300 x 100
- Day's Range
2.3000 - 2.4000 - 52 Week Range
2.2800 - 44.8800 - Volume
72,063 - Avg. Volume
100,662 - Market Cap (intraday)
7.45M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-29.5600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
12.00
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
ibs.incRecent News: INBS
Performance Overview: INBS
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INBS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INBS
Valuation Measures
Market Cap
7.45M
Enterprise Value
-1.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.73
Price/Book (mrq)
0.67
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-45.62%
Return on Equity (ttm)
-118.96%
Revenue (ttm)
2.83M
Net Income Avi to Common (ttm)
-10.03M
Diluted EPS (ttm)
-29.5600
Balance Sheet and Cash Flow
Total Cash (mrq)
9.4M
Total Debt/Equity (mrq)
8.49%
Levered Free Cash Flow (ttm)
-3.16M
Research Analysis: INBS
Company Insights: INBS
INBS does not have Company Insights